Terumo Corporation Product Pipeline AnalysisSummaryThis report is an insightful source for data, analysis and strategic insights into a Scope's pipeline and investigational products. The report also provides details on clinical trials covering trial phase, description, investigator information, primary and secondary end-points and trial results for products in development.Scope' Details of development stage by sector and equipment type.' Pipeline products grouped by therapy area, development stage and trial phase.' Detailed information on clinical trials covering trial phase, description, investigator information, primary and secondary end-points and trial results.' Trial updates, trial start and end dates, patient numbers and the trials primary outcome measures, secondary outcome measures.' Product updates covering estimated approval dates and estimated launch dates.' Descriptions of novel technologies relating to pipeline products of the company.' Patents and patent applications covered for the product.' News updates on key events relating to the product and its development.Reasons to buy' A single source to fulfill competitor information relating to products in development.' Identify pipeline products that are potential competitor to your product lines.' Understand a company's strategic position by accessing detailed independent intelligence on its product pipeline.' Access clinical trial information to map trial results and plan targeted marketing activities.' Take corrective measures on your own development programs and R&D initiatives based on regulatory events of competitor product pipelines.' Identification of potential investment opportunities.' Build up knowledge base for potential distribution and marketing partners.' Helps avoid patent infringement.' Timelines from concept to market lets you keep track of market potential build for a new product.' Assess a company's future growth by determining its pipeline depth, for probable acquisition opportunities.

1. Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!
Terumo Corporation Product Pipeline Analysis
Published on January 2009
Report Summary
Terumo Corporation Product Pipeline Analysis
Summary
This report is an insightful source for data, analysis and strategic insights into a Scope's pipeline and investigational products. The
report also provides details on clinical trials covering trial phase, description, investigator information, primary and secondary
end-points and trial results for products in development.
Scope
' Details of development stage by sector and equipment type.
' Pipeline products grouped by therapy area, development stage and trial phase.
' Detailed information on clinical trials covering trial phase, description, investigator information, primary and secondary end-points
and trial results.
' Trial updates, trial start and end dates, patient numbers and the trials primary outcome measures, secondary outcome measures.
' Product updates covering estimated approval dates and estimated launch dates.
' Descriptions of novel technologies relating to pipeline products of the company.
' Patents and patent applications covered for the product.
' News updates on key events relating to the product and its development.
Reasons to buy
' A single source to fulfill competitor information relating to products in development.
' Identify pipeline products that are potential competitor to your product lines.
' Understand a company's strategic position by accessing detailed independent intelligence on its product pipeline.
' Access clinical trial information to map trial results and plan targeted marketing activities.
' Take corrective measures on your own development programs and R&D initiatives based on regulatory events of competitor product
pipelines.
' Identification of potential investment opportunities.
' Build up knowledge base for potential distribution and marketing partners.
' Helps avoid patent infringement.
' Timelines from concept to market lets you keep track of market potential build for a new product.
' Assess a company's future growth by determining its pipeline depth, for probable acquisition opportunities.
Table of Content
1 Table of Contents 2
1.1 List of Tables 5
Terumo Corporation Product Pipeline Analysis Page 1/6

2. Find Industry reports, Company profiles
ReportLinker and Market Statistics
1.2 List of Figures 6
2 Company Snapshot 7
2.1 Key Information 7
2.2 Company Overview 7
3 Terumo Corporation Pipeline Products 8
3.1 Terumo Corporation Product Pipeline Analysis 8
3.1.1 Terumo Corporation Pipeline Products By Equipment Type 8
3.1.2 Terumo Corporation Pipeline Products By Development Stage 10
3.1.3 Terumo Corporation Pipeline Products By Therapy Area 10
3.1.4 Terumo Corporation Pipeline Products By Clinical Trials 10
3.1.5 Terumo Corporation Pipeline Products By News Summary 11
3.2 DuraHeart Left Ventricular Assist System 12
3.2.1 Product Status 12
3.2.2 Product Description 13
3.2.3 Product Milestone 13
3.2.4 DuraHeart Left Ventricular Assist SystemClinical Trials 1 14
3.2.5 DuraHeart Left Ventricular Assist SystemClinical Trials 2 15
3.2.6 Product Patent Details 15
3.3 Anaconda Endovascular Stent Graft 17
3.3.1 Product Status 17
3.3.2 Product Description 17
3.3.3 Product Milestone 18
3.3.4 Anaconda Endovascular Stent GraftClinical Trials 1 18
3.3.5 Anaconda Endovascular Stent GraftClinical Trials 2 18
3.4 Nobori Stent 19
3.4.1 Product Status 19
3.4.2 Product Description 20
3.4.3 Product Milestone 20
3.4.4 Clinical Trials 20
3.5 MISAGO peripheral stent 21
3.5.1 Product Status 21
3.5.2 Product Description 21
3.5.3 MISAGO peripheral stentClinical Trials 1 22
3.5.4 MISAGO peripheral stentClinical Trials 2 22
4 Recent Developments 24
4.1 Product News 24
4.1.1 Oct 31, 2008: Terumo Announces First Implant Of DuraHeart Left Ventricular Assist System (LVAS) In Japanese Clinical Trial
24
4.1.2 Oct 21, 2008: Discharge Of First DuraHeart Patient 24
4.1.3 Aug 21, 2008: Discharge Of First United States DuraHeart Patient 24
4.1.4 Aug 13, 2008: Three-G Heart-Helper Pump Tested 25
4.1.5 Aug 05, 2008: First US Patient To Receive New Heart Device Doing Well At U-M 25
4.1.6 Jun 25, 2008: Terumo Heart Obtains IRB Approval From The University Of Michigan To Initiate DuraHeart Left Ventricular
Assist System US Pivotal Trial 26
4.1.7 Apr 28, 2008: Terumo Heart Summarizes Results Of DuraHeart LVAS Implants 26
4.1.8 Mar 03, 2008: DuraHeart LVAS Receives Conditional Approval For US Pivotal Trial 27
4.1.9 Feb 18, 2008: Terumo Announces First CE Certified Nobori DES In Use 27
4.1.10 Jan 28, 2008: Terumo Launches The New AZUR Peripheral HydroCoil Embolization System 27
4.1.11 Jan 16, 2008: TERUMO Receives CE Certificate For Nobori Drug-Eluting Stent 28
4.1.12 Dec 21, 2007: Terumo Recalls Vascular Graft 28
Terumo Corporation Product Pipeline Analysis Page 2/6

3. Find Industry reports, Company profiles
ReportLinker and Market Statistics
4.1.13 Oct 22, 2007: Terumo's Nobori Drug Eluting Stent System Continues To Show Excellent Results 28
4.1.14 Sep 17, 2007: Terumo Heart Reports Summary Of Duraheart LVAD Clinical Trial Results 29
4.1.15 Jun 20, 2007: Implantation Technique For The Duraheart Left Ventricular Assist System 29
4.1.16 Feb 28, 2007: Terumo Heart Inc. Receives CE Mark For Left Ventricular Assist System In Europe 29
4.1.17 Nov 01, 2006: The Duraheart VAD, A Magnetically Levitated Centrifugal Pump Shows Clinical Results 30
4.1.18 Oct 24, 2006: Terumo's Nobori Drug-Eluting Coronary Stent Confirmed Non-inferior To Taxus Express In NOBORI 1 First
Phase Clinical Trial 30
4.1.19 May 27, 2005: Terumo Europe N.V. Enrolls First Patient In Clinical Trial Of Nobori Drug-Eluting Coronary Stent 30
4.1.20 Jul 09, 2004: First Vascutek Anaconda Grafts Implanted in US 30
4.1.21 Jan 21, 2004: First Implantation Worldwide Of DuraHeart Left-Ventricular Assist Device Successful 31
4.1.22 Oct 30, 2002: Vascutek Announces The Restart Of The Clinical Evaluation Of The Anaconda Aneurysm Repair System 31
4.2 Product Approvals 31
4.2.1 Jan 16, 2008: TERUMO Receives CE Certificate For Nobori Drug-Eluting Stent 31
4.2.2 Feb 28, 2007: Terumo Heart Inc. Receives CE Mark For Left Ventricular Assist System In Europe 31
4.3 Clinical Trials 32
4.3.1 Oct 31, 2008: Terumo Announces First Implant Of DuraHeart Left Ventricular Assist System (LVAS) In Japanese Clinical Trial
32
4.3.2 Oct 21, 2008: Discharge Of First DuraHeart Patient 32
4.3.3 Aug 21, 2008: Discharge Of First United States DuraHeart Patient 32
4.3.4 Aug 13, 2008: Three-G Heart-Helper Pump Tested 33
4.3.5 Aug 05, 2008: First US Patient To Receive New Heart Device Doing Well At U-M 33
4.3.6 Jun 25, 2008: Terumo Heart Obtains IRB Approval From The University Of Michigan To Initiate DuraHeart Left Ventricular
Assist System US Pivotal Trial 34
4.3.7 Apr 28, 2008: Terumo Heart Summarizes Results Of DuraHeart LVAS Implants 34
4.3.8 Mar 03, 2008: DuraHeart LVAS Receives Conditional Approval For US Pivotal Trial 35
4.3.9 Oct 22, 2007: Terumo's Nobori Drug Eluting Stent System Continues To Show Excellent Results 35
4.3.10 Sep 17, 2007: Terumo Heart Reports Summary Of Duraheart LVAD Clinical Trial Results 36
4.3.11 Nov 01, 2006: The Duraheart VAD, A Magnetically Levitated Centrifugal Pump Shows Clinical Results 36
4.3.12 Oct 24, 2006: Terumo's Nobori Drug-Eluting Coronary Stent Confirmed Non-inferior To Taxus Express In NOBORI 1 First
Phase Clinical Trial 36
4.3.13 May 27, 2005: Terumo Europe N.V. Enrolls First Patient In Clinical Trial Of Nobori Drug-Eluting Coronary Stent 37
4.3.14 Jul 09, 2004: First Vascutek Anaconda Grafts Implanted in US 37
4.3.15 Oct 30, 2002: Vascutek Announces The Restart Of The Clinical Evaluation Of The Anaconda Aneurysm Repair System 37
5 Appendix 38
5.1 Methodology 38
5.1.1 Coverage 38
5.1.2 Secondary Research 39
5.1.3 Primary Research 39
5.1.4 Expert Panel Validation 40
5.2 Contact Us 40
5.3 About Global Markets Direct 40
5.4 Disclaimer 40
1.2 List of Figures
Figure 1: Terumo Corporation Pipeline Products By Equipment Type 8
Figure 2: Terumo Corporation Pipeline Products By Equipment Type 9
Figure 3: Terumo Corporation Pipeline Products By News Summary 11
Figure 4: Global Markets Direct Methodology 38
Terumo Corporation Product Pipeline Analysis Page 3/6

4. Find Industry reports, Company profiles
ReportLinker and Market Statistics
Terumo Corporation Product Pipeline Analysis Page 4/6

5. Find Industry reports, Company profiles
ReportLinker and Market Statistics
Fax Order Form
To place an order via fax simply print this form, fill in the information below and fax the completed form to:
Europe, Middle East and Africa : + 33 4 37 37 15 56
Asia, Oceania and America : + 1 (805) 617 17 93
If you have any questions please visit http://www.reportlinker.com/notify/contact
Order Information
Please verify that the product information is correct and select the format(s) you require.
Terumo Corporation Product Pipeline Analysis
Product Formats
Please select the product formats and the quantity you require.
Digital Copy--USD 750.00 Quantity: _____
Contact Information
Please enter all the information below in BLOCK CAPITALS
Title: Mr Mrs Dr Miss Ms Prof
First Name: _____________________________ Last Name: __________________________________
Email Address: __________________________________________________________________________
Job Title: __________________________________________________________________________
Organization: __________________________________________________________________________
Address: __________________________________________________________________________
City: __________________________________________________________________________
Postal / Zip Code: __________________________________________________________________________
Country: __________________________________________________________________________
Phone Number: __________________________________________________________________________
Fax Number: __________________________________________________________________________
Terumo Corporation Product Pipeline Analysis Page 5/6

6. Find Industry reports, Company profiles
ReportLinker and Market Statistics
Payment Information
Please indicate the payment method, you would like to use by selecting the appropriate box.
Payment by credit card Card Number: ______________________________________________
Expiry Date __________ / _________
CVV Number _____________________
Card Type (ex: Visa, Amex…) _________________________________
Payment by wire transfer Crédit Mutuel
RIB : 10278 07314 00020257701 89
BIC : CMCIFR2A
IBAN : FR76 1027 8073 1400 0202 5770 189
Payment by check UBIQUICK SAS
16 rue Grenette – 69002 LYON, FRANCE
Customer signature:
Please note that by ordering from Reportlinker you are agreeing to our Terms and Conditions at
http://www.reportlinker.com/index/terms
Please fax this form to:
Europe, Middle East and Africa : + 33 4 37 37 15 56
Asia, Oceania and America : + 1 (805) 617 17 93
Terumo Corporation Product Pipeline Analysis Page 6/6